Quest Magazine

Shape of Genetic Material Matters in C9ORF72-Related ALS

MDA Thrilled FDA Will Consider Accelerated Approval for New Muscle Disease Drug Aimed at DMD

Dutch Bros. Coffee Annual “Drink One for Dane” Day to Donate Proceeds to Muscular Dystrophy Association

MTM: Down With Dynamin 2

MDA to Fund 38 New Research Grants

Siblings of Children with Neuromuscular Diseases Need Attention, Too

Leading the Way: MDA’s critical support for people with ALS

Pain in Neuromuscular Diseases: Who Knew?

Sailormen Inc. Popeyes “Appetite for A Cure” Raises Record $539,863 for MDA

New Forms of Genetic Testing Improve Diagnosis, Raise Questions

“Knowing, if not all, is almost all,” said Matthew Harms, a neurologist and neurophysiologist from Washington University in St. Louis, in his presentation on genetic testing for neuromuscular disorders at the 2014 MDA Clinical Conference, held in Chicago March 16-19.

Pages